title: Corticotropin-releasing hormone and adrenocorticotropic hormone concentrations in cerebrospinal fluid of dogs with pituitary-dependent hyperadrenocorticism.
abstract: There is still some controversy concerning the question of whether Cushing's disease in man is caused by a primary dysfunction of the pituitary or a hypothalamic disorder. In the latter option, excessive hypothalamic stimulation of pituitary corticotropes would cause or contribute to the genesis of POMC-secreting adenomas. In the present study cerebrospinal fluid (CSF) CRH levels and levels of ACTH and cortisol in CSF and plasma were measured in clinically healthy dogs, in dogs with pituitary-dependent hyperadrenocorticism (PDH), and in dogs with hyperadrenocorticism due to an adrenocortical tumor (ATH). In CSF from dogs with PDH, CRH concentrations (226.6 +/- 14.4 ng/liter) were significantly (P < 0.05) lower than those in control dogs (309.5 +/- 20.3 ng/liter). In the dogs with ATH, CSF CRH concentrations (211.0 +/- 40.3 ng/liter) were in the range of those in PDH dogs. In dogs with ATH, CSF ACTH levels (13.0 +/- 3.0 ng/liter) were significantly (P < 0.05) lower than those in control dogs (63.4 +/- 3.5 ng/liter), whereas in dogs with PDH, the levels (116.8 +/- 47.5 ng/liter) were not different from those in the control group. In control dogs, the concentrations of CSF CRH and plasma ACTH were significantly correlated (r = 0.635; P < 0.01). This functional dependency appeared to be disturbed in dogs with PDH, as in these dogs CSF CRH concentrations did not correlate with plasma ACTH concentrations. It is concluded that continuous hyperstimulation of pituitary corticotropes with hypothalamic CRH is probably not the cause of excessive ACTH secretion in dogs with pituitary-dependent hyperadrenocorticism.
authors.affiliation: Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, University of Utrecht, The Netherlands.
authors.forename: P A
authors.initials: PA
authors.lastname: Van Wijk
authors.forename: A
authors.initials: A
authors.lastname: Rijnberk
authors.forename: R J
authors.initials: RJ
authors.lastname: Croughs
authors.forename: G
authors.initials: G
authors.lastname: Voorhout
authors.forename: E P
authors.initials: EP
authors.lastname: Sprang
authors.forename: J A
authors.initials: JA
authors.lastname: Mol
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000150:complications; D000308:Adrenocortical Hyperfunction / Q000134:cerebrospinal fluid* / Q000209:etiology / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000134:cerebrospinal fluid*; D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000097:blood / Q000134:cerebrospinal fluid*; D004285:Dogs; D005260:Female; D006854:Hydrocortisone / Q000097:blood / Q000134:cerebrospinal fluid; D008297:Male; D010902:Pituitary Gland / Q000503:physiopathology*
chemical_list: D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone